Business

Bayer CEO Invoice Anderson says pharma rebuild 'progressing,' however patent cliff a priority – San Francisco Enterprise Instances – The Enterprise Journals



Bayer CEO Bill Anderson says pharma rebuild ‘progressing,’ but patent cliff a concern – San Francisco Business Times  The Business Journals



Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button